149 related articles for article (PubMed ID: 37341710)
1. Thrombotic thrombocytopenic purpura that developed 3 years after systemic lupus erythematosus had remitted with rituximab therapy.
Tsuda R; Kido T; Okada I; Kobiyama A; Kawataka M; Yamazaki M; Asano R; Hounoki H; Shinoda K; Tobe K
Mod Rheumatol Case Rep; 2023 Dec; 8(1):57-62. PubMed ID: 37341710
[TBL] [Abstract][Full Text] [Related]
2. Upfront rituximab therapy for thrombotic thrombocytopenic purpura in systemic lupus erythematosus: a case-based review.
Mutoh T; Ohashi K; Nagai T; Sugiura A; Kudo M; Fujii H
Rheumatol Int; 2023 Feb; 43(2):373-381. PubMed ID: 35962219
[TBL] [Abstract][Full Text] [Related]
3. Systemic Lupus Erythematosus Presenting as Refractory Thrombotic Thrombocytopenic Purpura: A Diagnostic and Management Challenge. A Case Report and Concise Review of the Literature.
Abu-Hishmeh M; Sattar A; Zarlasht F; Ramadan M; Abdel-Rahman A; Hinson S; Hwang C
Am J Case Rep; 2016 Oct; 17():782-787. PubMed ID: 27777394
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with combination of plasma exchange and low-dose rituximab.
Ma W; Bai W; Wu X; Zhao J; Li M; Zeng X
Lupus; 2020 Dec; 29(14):1961-1967. PubMed ID: 32838618
[TBL] [Abstract][Full Text] [Related]
5. A case of systemic lupus erythematosus having concurrent Evans syndrome and acquired thrombotic thrombocytopenic purpura.
Motoyama R; Higuchi T; Hirahara S; Konda N; Yamada R; Watanabe K; Fujisaki M; Yamaguchi R; Katsumata Y; Kawaguchi Y; Harigai M
Mod Rheumatol Case Rep; 2023 Jun; 7(2):383-387. PubMed ID: 36779528
[TBL] [Abstract][Full Text] [Related]
6. Sequential treatment of rituximab and belimumab in thrombotic thrombocytopenia purpura associated with systemic lupus erythematous: A respective case series and literature review.
Liu J; Yan M; Wen R; Li J
Int J Rheum Dis; 2023 May; 26(5):960-964. PubMed ID: 36592434
[TBL] [Abstract][Full Text] [Related]
7. Immune-mediated thrombotic thrombocytopenic purpura in patients with and without systemic lupus erythematosus: a retrospective study.
Yue C; Su J; Fan X; Song L; Jiang W; Xia J; Shi T; Zhang X; Li X
Orphanet J Rare Dis; 2020 Aug; 15(1):225. PubMed ID: 32859237
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report.
Kafle P; Malakoff GL
Tenn Med; 2012 May; 105(5):37-8. PubMed ID: 22611780
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous recovery in a patient with acquired thrombotic thrombocytopenic purpura (TTP): observation of a 'subclinical' TTP state.
Browning S; Bahar B; Lee AI; Gorshein E
Hematology; 2020 Dec; 25(1):473-477. PubMed ID: 33269995
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of thrombotic thrombocytopenic purpura with plasmapheresis and anti-CD20 antibodies in a patient with immune thrombocytopenia and systemic lupus erythematosus: Case report.
Jung JY; Kim JW; Suh CH; Kim HA
Medicine (Baltimore); 2022 Feb; 101(7):e28908. PubMed ID: 35363211
[TBL] [Abstract][Full Text] [Related]
11. Systemic lupus erythematosus and thrombotic thrombocytopenia purpura: a refractory case without lupus activity.
Garcia Boyero R; Mas Esteve E; Mas Esteve M; Millá Perseguer MM; Marco Buades J; Beltran Fabregat J; Cañigral Ferrando G; Belmonte Serrano MA
Reumatol Clin; 2013; 9(6):373-5. PubMed ID: 23473755
[TBL] [Abstract][Full Text] [Related]
12. Rituximab therapy for refractory thrombotic thrombocytopenic purpura and autoimmune-mediated thrombocytopenia in systemic lupus erythematosus.
Hundae A; Peskoe S; Grimsley E; Patel S
South Med J; 2008 Sep; 101(9):943-4. PubMed ID: 18708978
[TBL] [Abstract][Full Text] [Related]
13. [Thrombotic thrombocytopenic purpura - a rare cause of thrombocytopenia in systemic lupus erythematosus].
Natusch A; Gromnica-Ihle E
Dtsch Med Wochenschr; 2002 Sep; 127(37):1881-5. PubMed ID: 12226787
[TBL] [Abstract][Full Text] [Related]
14. Rituximab was effective on refractory thrombotic thrombocytopenic purpura but induced a flare of hemophagocytic syndrome in a patient with systemic lupus erythematosus.
Kamiya K; Kurasawa K; Arai S; Maezawa R; Hanaoka R; Kumano K; Fukuda T
Mod Rheumatol; 2010 Feb; 20(1):81-5. PubMed ID: 19784542
[TBL] [Abstract][Full Text] [Related]
15. Response to belimumab in thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a case-based review.
Liang SJ; Zheng QY; Li MS; Lv MY; Chen WT; Yang Y
Clin Rheumatol; 2022 Aug; 41(8):2561-2569. PubMed ID: 35524885
[TBL] [Abstract][Full Text] [Related]
16. Effect of rituximab on B cell phenotype and serum B cell-activating factor levels in patients with thrombotic thrombocytopenic purpura.
Becerra E; Scully MA; Leandro MJ; Heelas EO; Westwood JP; De La Torre I; Cambridge G
Clin Exp Immunol; 2015 Mar; 179(3):414-25. PubMed ID: 25339550
[TBL] [Abstract][Full Text] [Related]
17. Pancreatitis leading to thrombotic thrombocytopenic purpura in systemic lupus erythematosus: a case report and review of literature.
Singh R; Saunders B; Scopelitis E
Lupus; 2003; 12(2):136-9. PubMed ID: 12630759
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic thrombocytopenic purpura after ChAdOx1 nCoV-19 vaccine.
Lee HP; Selvaratnam V; Rajasuriar JS
BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34625443
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of refractory thrombotic thrombocytopenic purpura with cyclosporine and corticosteroids in a patient with systemic lupus erythematosus and antibodies to ADAMTS13.
Enami T; Suzuki T; Ito S; Yoshimi A; Sugihara M; Mamura M; Hayashi T; Goto D; Matsumoto I; Tsutsumi A; Sumida T
Intern Med; 2007; 46(13):1033-7. PubMed ID: 17603247
[TBL] [Abstract][Full Text] [Related]
20. Rituximab as first-line treatment for acquired thrombotic thrombocytopenic purpura.
Chen H; Fu A; Wang J; Wu T; Li Z; Tang J; Shen H; Zhu J; Li J; Zhu Q; Qing L
J Int Med Res; 2017 Jun; 45(3):1253-1260. PubMed ID: 28639502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
